Table 4.

The production of MDA in serum and homogenate after treatment (nmol/mL).

Groups	Serum	Homogenate
Control	9.8 ± 0.9	6.4 ± 0.2
Model	13.7 ± 0.7△	7.4 ± 0.2△△
DXM	14.0 ± 1.2	6.2 ± 0.2**
TA-H	11.9 ± 0.7	6.6 ± 0.4
TA-M	12.1 ± 2.0	6.2 ± 0.3
TA-L	11.0 ± 0.8*	6.1 ± 0.4*
Sch	12.2 ± 1.1	6.1 ± 0.4*
Epi	11.6 ± 0.9	6.4 ± 0.5
Val	11.1 ± 0.4**	7.1 ± 0.5
Pic	11.2 ± 1.4	6.2 ± 0.5

Note: Data are expressed as mean ± SEM. Statistical differences are represented as ^△p < 0.05, ^△△p < 0.01 vs. control, ^*p < 0.05, ^**p < 0.01 vs. model (n = 10 mice per group). MDA, malondialdehyde. All groups were intra-gastrically administrated.